Elsevier Inc.

SHERPA: Unknown

People

  1. Rusch
    Rusch
  2. Travis
    Travis
  3. Kris
    Kris
  4. Park
    Park
  5. Adusumilli
    Adusumilli
  6. Bains
    Bains
  7. Riely
    Riely
  8. Seshan
    Seshan
  9. Zhou
    Zhou
  10. Chaft
    Chaft

Groups

  1. Surgery (7)
  2. Survivorship Research (4)
  3. Department of Medicine (3)
  4. Solid Tumor Oncology Division (3)
  5. Thoracic Oncology (3)
  6. Biostatistics Service (2)
  7. Body Imaging Service (2)
  8. Center for Pancreatic Cancer Research (2)
  9. Epidemiology and Biostatistics (2)
  10. Radiology, Department of (2)
Search Within
  1. "David Finley"
  2. "Valerie Rusch"
Formats
  1. Meeting Abstract (4)
  2. Journal Article (3)
Groups
  1. Surgery (7)
  2. Survivorship Research (4)
  3. Department of Medicine (3)
  4. Solid Tumor Oncology Division (3)
  5. Thoracic Oncology (3)
  6. Biostatistics Service (2)

More Groups

People
  1. David Finley (7)
  2. Valerie Rusch (7)
  3. William Travis (5)
  4. Bernard Park (3)
  5. Mark Kris (3)
  6. Akihiko Yoshizawa (2)

More People

Years
  1. 2014 (1)
  2. 2013 (2)
  3. 2010 (1)
  4. 2009 (2)
  5. 2007 (1)
Publications
  1. Journal of Thoracic Oncology (7)

Results (7)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Comprehensive pathological analyses in lung squamous cell carcinoma: Single cell invasion, nuclear diameter, and tumor budding are independent prognostic factors for worse outcomes
    Journal Article

    Kadota, K.; Nitadori, J. I.; Woo, K. M.; Sima, C. S.; Finley, D. J.; Rusch, V. W.; Adusumilli, P. S.; Travis, W. D.
    Journal of Thoracic Oncology (2014)

    Fulltext@MSK | Save
  • Tumor budding and nuclear grade, but not histologic subtype, are significant prognostic factors, independent of TNM stage, in patients with lung squamous cell carcinoma
    Meeting Abstract

    Kadota, K.; Nitadori, J.; Finley, D. J.; Rusch, V. W.; Adusumilli, P. S.; Travis, W. D.
    Journal of Thoracic Oncology (2013)

    Fulltext@MSK | Save
  • Phase II trial of neoadjuvant bevacizumab plus chemotherapy and adjuvant bevacizumab in patients with resectable nonsquamous non-small-cell lung cancers
    Journal Article

    Chaft, J. E.; Rusch, V.; Ginsberg, M. S.; Paik, P. K.; Finley, D. J.; Kris, M. G.; Price, K. A. R.; Azzoli, C. G.; Fury, M. G.; Riely, G. J.; more...
    Journal of Thoracic Oncology (2013)

    Fulltext@MSK | Save
  • Predictors of outcomes after surgical treatment of synchronous primary lung cancers
    Journal Article

    Finley, D. J.; Yoshizawa, A.; Travis, W.; Zhou, Q.; Seshan, V. E.; Bains, M. S.; Flores, R. M.; Rizk, N.; Rusch, V. W.; Park, B. J.
    Journal of Thoracic Oncology (2010)

    Fulltext@MSK | Save
  • Reflex testing of lung adenocarcinomas for EGFR and KRAS mutations: The initial Memorial Sloan-Kettering Cancer Center (MSKCC) experience
    Meeting Abstract

    Zakowski, M. F.; Ladanyi, M.; Rekhtman, N.; Park, B.; Finley, D.; Azzoli, C.; Kris, M. G.; Rusch, V.; Miller, V.; Riely, G.
    Journal of Thoracic Oncology (2009)

    Fulltext@MSK | Save
  • Phase II trial of induction and adjuvant bevacizumab with cisplatin and docetaxel in patients with locally advanced NSCLC
    Meeting Abstract

    Kris, M. G.; Price, K. A.; Rusch, V. W.; Zhao, B. S.; Schwartz, L. H.; Guo, P. Z.; Tan, Y. Q.; Subzwari, S.; Finley, D.; Rizvi, N. A.
    Journal of Thoracic Oncology (2009)

    Fulltext@MSK | Save
  • Predictors of outcomes after surgical treatment of synchronous primary lung cancers
    Meeting Abstract

    Finley, D. J.; Yoshizawa, A.; Zhou, Q. C.; Seshan, V. E.; Rusch, V. W.; Travis, W. D.; Park, B. J.
    Journal of Thoracic Oncology (2007)

    Fulltext@MSK | Save